| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
71,210,000 |
| Market
Cap: |
532.65(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$6.5 - $15.02 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Accolade provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. Co.'s offerings include: Accolade Expert MD, which is a medical consultations that connect patients to specialists for both adult and pediatric care; Accolade Care, which is an integrated primary care and mental health support; Core and Plus, which is a benefits navigation and care solution incorporating Co.'s solutions including Advocacy, Accolade Expert MD, Accolade Care, and the Accolade partner ecosystem; and Accolade One, which is an option that includes all of the Co.'s solutions and the Accolade partner ecosystem.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
17,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$176,530 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
8,613 |
142,272 |
188,114 |
201,802 |
| Total Sell Value |
$79,541 |
$2,059,087 |
$2,613,282 |
$2,729,086 |
| Total People Sold |
5 |
5 |
6 |
6 |
| Total Sell Transactions |
25 |
51 |
121 |
169 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barnes Stephen H. |
Chief Financial Officer |
• • – |
2023-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,239 |
143,773 |
|
- |
|
| Cavanaugh Robert N |
President |
• • – |
2023-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,524 |
165,989 |
|
- |
|
| Eskew Richard |
EVP General Counsel |
• • – |
2023-06-02 |
4 |
S |
$12.84 |
$14,735 |
D/D |
(1,148) |
28,159 |
|
36% |
|
| Eskew Richard |
EVP General Counsel |
• • – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,139 |
25,557 |
|
- |
|
| Nabel Elizabeth G |
Director |
• • – |
2023-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,752 |
4,757 |
|
- |
|
| Brodsky Jeffrey S |
Director |
• • – |
2023-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,752 |
9,585 |
|
- |
|
| Eskew Richard |
EVP General Counsel |
• • – |
2023-05-26 |
4 |
S |
$11.38 |
$3,937 |
D/D |
(346) |
25,168 |
|
26% |
|
| Singh Rajeev |
Chief Executive Officer |
• • – |
2023-05-26 |
4 |
S |
$11.38 |
$17,205 |
D/D |
(1,512) |
569,238 |
|
26% |
|
| Hilton Michael W |
Director |
• • – |
2023-05-26 |
4 |
S |
$11.38 |
$5,746 |
D/D |
(505) |
139,145 |
|
26% |
|
| Barnes Stephen H. |
Chief Financial Officer |
• • – |
2023-05-26 |
4 |
S |
$11.38 |
$6,975 |
D/D |
(613) |
134,534 |
|
26% |
|
| Cavanaugh Robert N |
President |
• • – |
2023-05-26 |
4 |
S |
$11.38 |
$8,102 |
D/D |
(712) |
157,465 |
|
26% |
|
| Eskew Richard |
EVP General Counsel |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,273 |
25,514 |
|
- |
|
| Singh Rajeev |
Chief Executive Officer |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,039 |
570,750 |
|
- |
|
| Hilton Michael W |
Director |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,262 |
139,650 |
|
- |
|
| Barnes Stephen H. |
Chief Financial Officer |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,262 |
135,147 |
|
- |
|
| Cavanaugh Robert N |
President |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,484 |
158,177 |
|
- |
|
| Singh Rajeev |
Chief Executive Officer |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,038 |
570,749 |
|
- |
|
| Singh Rajeev |
Chief Executive Officer |
• • – |
2023-05-25 |
4 |
S |
$11.23 |
$17,217 |
D/D |
(1,533) |
566,711 |
|
13% |
|
| Cavanaugh Robert N |
President |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,483 |
158,176 |
|
- |
|
| Cavanaugh Robert N |
President |
• • – |
2023-05-25 |
4 |
S |
$11.23 |
$8,098 |
D/D |
(721) |
155,693 |
|
13% |
|
| Eskew Richard |
EVP General Counsel |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,272 |
24,592 |
|
- |
|
| Eskew Richard |
EVP General Counsel |
• • – |
2023-05-25 |
4 |
S |
$11.23 |
$3,942 |
D/D |
(351) |
24,241 |
|
13% |
|
| Barnes Stephen H. |
Chief Financial Officer |
• • – |
2023-05-25 |
4 |
S |
$11.23 |
$6,986 |
D/D |
(622) |
132,885 |
|
13% |
|
| Barnes Stephen H. |
Chief Financial Officer |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,261 |
133,507 |
|
- |
|
| Hilton Michael W |
Director |
• • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,261 |
139,649 |
|
- |
|
491 Records found
|
|
Page 10 of 20 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.15 (2.05%) 
